ROIVANT SCIENCES LTD. manufactures biopharmaceutical products. Its products include drugs and medicines for prostrate cancer, neurological disorders, cardio metabolic disorders, urological infections, dermatology, hepatitis B, immunology, and reparatory infections. The company sells its products under the name of myovant, enzyvant, axovant, metavant, urovant, dermavant, immunovant, altavant, respivant, and sinovant. The company was founded in 2014 and is based in London, United Kingdom.